Overview

Parenteral Drugs Market Introduction

FutureWise Market Research has instantiated a report that provides an intricate analysis of Parenteral Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Parenteral Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Parenteral Drugs Market:
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd.
• AstraZeneca Plc
• Merck & Co., Inc.
• Mylan N.V
• Cipla Inc.
• Dr. Reddy’s Laboratories Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Parenteral Drugs Market Segmentation:
By Product Type
• Monoclonal Antibodies
• Immunoglobulin
• Cytokines
• Insulin
• Peptide Hormones
• Blood Factors
• Peptide Antibiotics
• Vaccines
• Small Molecule Antibiotics
• Chemotherapy Agents
• Others
 

By Application
• Oncology
• Infectious Diseases
• Diabetes
• Blood disorders
• Hormonal Disorders
• Musculoskeletal Disorders
• CNS Diseases
• Pain Management
• Cardiovascular Diseases
 

By Molecule Type
• Small Molecules
• Large Molecules
 

By Route of Administration
• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
 

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
 

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Parenteral Drugs Market By Product Type, By Application, By Molecule Type, By Route of Administration, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Parenteral Drugs Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Application Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Parenteral Drugs Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Parenteral Drugs Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Application Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Application Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Parenteral Drugs Market, By Product Type  Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Monoclonal Antibodies
  7.2. Immunoglobulin
  7.3. Cytokines
  7.4. Insulin
  7.5. Peptide Hormones
  7.6. Blood Factors
  7.7. Peptide Antibiotics
  7.8. Vaccines
  7.9. Small Molecule Antibiotics
  7.10. Chemotherapy Agents
  7.11. Others

8. Global Parenteral Drugs Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Oncology
  8.2. Infectious Diseases
  8.3. Diabetes
  8.4. Blood disorders
  8.5. Hormonal Disorders
  8.6. Musculoskeletal Disorders
  8.7. CNS Diseases
  8.8. Pain Management
  8.9. Cardiovascular Diseases

9. Global Parenteral Drugs Market, By Molecule Type Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Small Molecules
  9.2. Large Molecules

10. Global Parenteral Drugs Market, By Route of Administration Historical Analysis and Forecast 2020-2027 (USD Million)
   10.1. Intravenous (IV)
   10.2. Intramuscular (IM)
   10.3. Subcutaneous (SC)

11. Global Parenteral Drugs Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million)
   11.1. Hospital Pharmacies
   11.2. Retail Pharmacies
   11.3. Drug Stores
   11.4. Online Pharmacies

12. North America Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Saudi Arabia
         16.2.2. UAE
         16.2.3. South Africa
         16.2.4. Egypt
   16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4.  North America - Market Share Analysis and Key Regional Players
   17.5.  Europe - Market Share Analysis and Key Regional Players
   17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts)
   18.1. Pfizer Inc.
         18.1.1. Company Overview
         18.1.2. Product Type Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Novartis AG
         18.2.1. Company Overview
         18.2.2. Product Type Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Teva Pharmaceutical Industries Ltd.
         18.3.1. Company Overview
         18.3.2. Product Type Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. PathoFinder BV
         18.4.1. Company Overview
         18.4.2. Product Type Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5 Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd.
         18.5.1. Company Overview
         18.5.2. Product Type Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6 AstraZeneca Plc
         18.6.1. Company Overview
         18.6.2. Product Type Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Merck & Co., Inc.
         18.7.1. Company Overview
         18.7.2. Product Type Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. Mylan N.V
         18.8.1. Company Overview
         18.8.2. Product Type Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Cipla Inc.
         18.9.1. Company Overview
         18.9.2. Product Type Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10. Dr. Reddy’s Laboratories Ltd.
         18.10.1.Company Overview
         18.10.2.Product Type Portfolio
         18.10.3.SWOT Analysis
         18.10.4.Financial Overview
         18.10.5.Strategic Overview


19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures